Long-term assessment of patients with Primary Sjögren's Syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ASSESS national multi-center prospective cohort aims to evaluate the evolution and systemic complications of patients with Primary Sjögren's Syndrome (pSS) over a 20-year period. This observational study includes patients who meet the American-European Consensus Criteria for pSS and collects data on various systemic complications and predictors of lymphoma. Conducted across 15 centers in France, the study utilizes standardized case report forms filled out by clinicians annually. The cohort has previously followed 395 patients for 5 years, and the extension will continue to gather valuable insights into the disease's progression.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* aged of 18 years or more
* Primary Sjögren's Syndrome Patients who have already participated to the study ASSESS

Exclusion Criteria:

* secondary Sjögren's Syndrome (SJ) associated with other autoimmune diseases

Where it's running

• Hopital Bicêtre
  Le Kremlin-Bicêtre, Val De Marne, France Recruiting

Study contacts

• Principal investigator: Xavier Mariette — Sfr/ap-Hp
• Study coordinator: Xavier Mariette
• Email: xavier.mariette@aphp.fr
• Phone: 01.45.21.37.58

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating a Biomarker for Disease Activity in Primary Sjögren's Syndrome

  This study is testing if measuring a specific type of antibody in the blood can help doctors understand how active the disease is in people with Primary Sjögren's Syndrome.

  Recruiting at 5 sites Centre Hospitalier Universitaire de Saint Etienne · Bourgoin and 7 other locations · NCT03003572

• Using PSMA and FAPI PET scans to map salivary gland function and inflammation in Sjögren's syndrome

  This study will test whether combining PSMA and FAPI PET scans can better show salivary gland function and inflammation in people with primary Sjögren's syndrome.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT07324733

• Anti-CD19/BCMA U CAR-T cell therapy for relapsed or refractory autoimmune diseases

  This pilot will test whether anti-CD19/BCMA U CAR-T cells can help adults with relapsed or refractory autoimmune diseases such as SLE, systemic sclerosis, Sjögren's syndrome, and rheumatoid arthritis.

  Recruiting Early Phase 1 Changhai Hospital · Shanghai · NCT07246096

• Creating a clinical model for primary Sjögren's syndrome using both traditional Chinese and Western medicine

  This study is trying to combine traditional Chinese medicine with Western medicine to see if it can improve how we diagnose and manage primary Sjögren's syndrome in patients.

  Recruiting China-Japan Friendship Hospital · Beijing, Beijing Municipality · NCT06528197

• Impact of Sjögren's syndrome on quality of life and costs

  This study is trying to see how small fiber neuropathy affects the quality of life and costs for people with Sjögren's syndrome.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT03509064

• Evaluating diagnostic methods for Primary Sjögren's Syndrome

  This study is testing different ways to diagnose Primary Sjögren's Syndrome to see which methods work best for patients who might have it.

  Recruiting University Hospital, Brest · Brest · NCT03681964

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.